MedTrace Logo

A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy

NCT02920593 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 412

Last updated 2017-10-05

No results posted yet for this study

Summary

The investigators aim to determine if Vitamin D prophylaxis in pregnancy reduces the incidence of hypertensive disorders of pregnancy.

Conditions

  • Gestational Hypertension
  • Toxemia
  • Superimposed Preeclampsia
  • Eclampsia
  • HELLP Syndrome

Interventions

DRUG

Vitamin D3

Vitamin D prophylaxis

Sponsors & Collaborators

Principal Investigators

  • Diana J Garretto, MD · SUNY Stony Brook Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-07-31
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920593 on ClinicalTrials.gov